BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 2130662)

  • 1. Lesions of the nucleus basalis magnocellularis in the rat: morphological, biochemical and behavioral reparative effect of nerve growth factor and ganglioside GM1.
    Casamenti F; Milan F; Pepeu G
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):461-73. PubMed ID: 2130662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
    Garofalo L; Cuello AC
    Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for nerve growth factor-ganglioside interaction in forebrain cholinergic neurons.
    Cuello AC; Garofalo L; Maysinger D
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):451-60. PubMed ID: 2130661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
    Garofalo L; Cuello AC
    J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis.
    Di Patre PL; Casamenti F; Cenni A; Pepeu G
    Brain Res; 1989 Feb; 480(1-2):219-24. PubMed ID: 2713652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nerve growth factor and GM1 ganglioside on the number and size of cholinergic neurons in rats with unilateral lesion of the nucleus basalis.
    Casamenti F; Di Patre PL; Milan F; Petrelli L; Pepeu G
    Neurosci Lett; 1989 Aug; 103(1):87-91. PubMed ID: 2779858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 ganglioside facilitates the recovery of high-affinity choline uptake in the cerebral cortex of rats with a lesion of the nucleus basalis magnocellularis.
    Pedata F; Giovannelli L; Pepeu G
    J Neurosci Res; 1984; 12(2-3):421-7. PubMed ID: 6502759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats.
    Casamenti F; Scali C; Giovannelli L; Faussone-Pellegrini MS; Pepeu G
    J Neural Transm Park Dis Dement Sect; 1994; 7(3):177-93. PubMed ID: 7710670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA.
    Winkler J; Thal LJ
    Exp Neurol; 1995 Dec; 136(2):234-50. PubMed ID: 7498413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1.
    Garofalo L; Ribeiro-da-Silva A; Cuello AC
    Neuroscience; 1993 Nov; 57(1):21-40. PubMed ID: 8278055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the thyrotropin releasing hormone analogue posatirelin (RGH 2202) on microanatomical changes induced by lesions of the nucleus basalis magnocellularis in the rat.
    Panocka I; Coppi G; Maggioni A; Olgiati V; Sabbatini M; Amenta F
    Drugs Exp Clin Res; 1997; 23(1):13-23. PubMed ID: 9093818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
    Hu L; Côté SL; Cuello AC
    Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects.
    Maysinger D; Jalsenjak V; Stolnik S; Garofalo L; Cuello AC; Jalsenjak I
    J Microencapsul; 1989; 6(1):35-42. PubMed ID: 2715912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term protective effects of human recombinant nerve growth factor and monosialoganglioside GM1 treatment on primate nucleus basalis cholinergic neurons after neocortical infarction.
    Liberini P; Pioro EP; Maysinger D; Ervin FR; Cuello AC
    Neuroscience; 1993 Apr; 53(3):625-37. PubMed ID: 8487947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of memory and cortical cholinergic neurochemical recovery with combine fetal transplantation and GM1 treatments in rats with lesions of the NBM.
    Santucci AC; Gluck R; Kanof PD; Haroutunian V
    Dementia; 1993; 4(5):273-81. PubMed ID: 8261024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
    Mandel RJ; Chen AD; Connor DJ; Thal LJ
    J Pharmacol Exp Ther; 1989 Nov; 251(2):612-9. PubMed ID: 2810114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus basalis magnocellularis lesions: lack of biochemical and immunocytochemical recovery and effect of cholinesterase inhibitors on passive avoidance.
    Thal LJ; Dokla CP; Armstrong DM
    Behav Neurosci; 1988 Dec; 102(6):852-60. PubMed ID: 3214535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does senile impairment of cholinergic system in rats concern only disturbances in cholinergic phenotype or the progressive degeneration of neuronal cell bodies?
    Niewiadomska G; Wyrzykowska J; Chechłacz M
    Acta Biochim Pol; 2000; 47(2):313-30. PubMed ID: 11051196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery.
    Pizzo DP; Thal LJ
    Neuroscience; 2004; 124(4):743-55. PubMed ID: 15026115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.